GI
TEVA icon

GAMMA Investing’s Teva Pharmaceuticals TEVA Stock Holding History

GAMMA Investing’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
11,361
+1,859
+20% +$61.9K 0.01% 797
2026
Q1 		$286K Sell
9,502
-250
-3% -$8.04K 0.01% 876
2025
Q4 		$304K Buy
9,752
+1,408
+17% +$34.7K 0.02% 755
2025
Q3 		$169K Buy
8,344
+1,062
+15% +$18.7K 0.01% 1097
2025
Q2 		$122K Buy
7,282
+2,892
+66% +$46.7K 0.01% 1279
2025
Q1 		$67.5K Sell
4,390
-3,068
-41% -$54.8K 0.01% 1570
2024
Q4 		$164K Buy
7,458
+2,297
+45% +$41.8K 0.01% 789
2024
Q3 		$93K Buy
5,161
+1,773
+52% +$31K 0.01% 1056
2024
Q2 		$55.1K Buy
3,388
+1,741
+106% +$26.8K 0.01% 1123
2024
Q1 		$23.2K Buy
1,647
+359
+28% +$4.53K ﹤0.01% 1542
2023
Q4 		$15.6K Buy
+1,288
New +$12K ﹤0.01% 1656

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GAMMA Investing's TEVA Position: Q2 2026 in Review

GAMMA Investing increased its Teva Pharmaceuticals (TEVA) stake by 20% in Q2 2026, buying an estimated $61.9K and bringing the position to 11,361 shares worth $385K. The position accounts for 0.01% of the portfolio, ranked #797.

GAMMA Investing first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GAMMA Investing held 11,361 shares of Teva Pharmaceuticals worth $385K as of Q2 2026.
  • GAMMA Investing bought 1,859 Teva Pharmaceuticals shares in Q2 2026, an estimated $61.9K.
  • Teva Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #797 holding.
  • GAMMA Investing first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.